Evidence map›Paper›PMID 33194204›Full record

ArticleSAGE open medical case reports2020

Vaping in today's pandemic: E-cigarette, or vaping, product use-associated lung injury mimicking COVID-19 in teenagers presenting with respiratory distress.

Daphne O Darmawan, Kriti Gwal, Brian D Goudy, Sanjay Jhawar, Kiran Nandalike

Open access · goldAbstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Development of the Respiratory System During Adolescence.Advances in experimental medicine and biology · 2026
    Review
  2. Review
  3. Article
  4. A Comprehensive Review of Vaping Use in Pediatric Patients and Recent Changes in Regulatory Laws.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Daphne O DarmawanDepartment of Pediatrics, University of California Davis Health, Sacramento, CA, USA.
Kriti GwalDivision of Pediatric Radiology, Department of Radiology, University of California Davis Health, Sacramento, CA, USA.
Brian D GoudyDivision of Critical Care Medicine, Department of Pediatrics, University of California Davis Health, Sacramento, CA, USA.
Sanjay JhawarDivision of Pulmonary Medicine, Department of Pediatrics, University of California Davis Health, Sacramento, CA, USA.
Kiran NandalikeDivision of Pulmonary Medicine, Department of Pediatrics, University of California Davis Health, Sacramento, CA, USA.ORCID https://orcid.org/0000-0002-0176-5617
University of California, Davis · USUniversity of California Davis Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical presentation of children and adolescents infected with severe acute respiratory syndrome coronavirus 2 can range from asymptomatic to mild or moderate manifestations. We present a case series of three adolescents who presented during the coronavirus disease 2019 (COVID-19) pandemic with symptoms concerning for COVID-19, including fever, abdominal symptoms, cough, respiratory distress, and hypoxemia. Their laboratory results showed elevated inflammatory markers that are also commonly seen in COVID-19. The chest imaging studies mimicked COVID-19 with non-specific ground glass opacities and interstitial prominence patterns. However, severe acute respiratory syndrome coronavirus 2 testing was negative and further questioning of these adolescents and their parents revealed a history of vaping marijuana-related products leading to the eventual diagnosis of e-cigarette, or vaping, product use-associated lung injury. Our patients were successfully treated with corticosteroids. The providers caring for pediatric patients, especially adolescents, should continue to have a high index of suspicion for e-cigarette, or vaping, product use-associated lung injury in patients presenting with unexplained respiratory failure, while ruling out COVID-19.

Indexed as

adolescentsCOVID-19critical care/emergency medicinee-cigaretteor vapingproduct use–associated lung injuryrespiratory medicineToxicology

Identifiers

PMID33194204
PMCPMC7607755
OpenAlexW3094942542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.